Transgender Puberty Blocking Drug Linked To Thousands Of Deaths, FDA Data Reveals

By  Amanda Prestigiacomo

More than 6,300 adults have died from reactions to a drug that is used as a puberty blocker in gender-confused children, Food & Drug Administration data reportedly shows.

“Between 2012 and June 30 of this year, the FDA documented over 40,764 adverse reactions suffered by patients who took Leuprolide Acetate (Lupron), which is used as a hormone blocker. More than 25,500 reactions logged from 2014-2019 were considered ‘serious,’ including 6,370 deaths,” The Christian Post reported on Thursday.

“Lupron is being prescribed off-label for use in children who have been diagnosed with gender dysphoria despite the lack of formal FDA approval for that purpose,” the outlet explained. “The drug is clinically approved for treatment of precocious puberty, a condition where children start their pubertal processes at an abnormally early age and the blocker is administered for a short time until the proper age.”

Michael Laidlaw, a California-based endocrinologist who exposed in April that doctors are giving testosterone to gender-confused girls as young as eight years old, questioned why a psychological disorder like gender dysphoria would be treated with such drugs, instead of “proper psychological care.”

“Gender dysphoria is not an endocrine condition, but is a psychological one and should, therefore, be treated with proper psychological care,” he said, according to The Christian Post. “But it becomes an endocrine condition once you start using puberty blockers and giving cross-sex hormones to kids.”

As highlighted by the outlet, drug sales for Lupron in the United States in 2017 hit about $669 million, an annual report for AbbVie, which produces the drug, showed.

As previously covered by The Daily Wire, Laidlaw, among other medical doctors and a parent of a gender-confused child, sounded the alarm on the increasing use of transgender-related drugs. The professionals discovered that government-funded research now allows children as young as eight to be put on sex hormones.

“Through FOIA requests, Laidlaw and some of his colleagues ‘found that in 2017 they lowered the minimum age for cross-sex hormones from 13 to 8,’” a report from The Christian Post published in April said.

“Imagine giving 8-year-old girls testosterone,” the endocrinologist offered. “They are in 3rd or 4th grade. This is unbelievable. But this is going on.”